Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2019-02-01
2020-02-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Antioxidants on Human Macular Pigments
NCT00718653
The Effects of LycoRed Phytonutrient and Vitamin Supplement (a.k.a. LYC-001e) on Ocular Blood Flow
NCT03068377
Association of Lutein, Zeaxanthin and Brilliant Blue in Chromovitrectomy
NCT01627977
Macular Pigment and Glare Disability
NCT00909090
Relationships Between Macular Pigment Optical Density and Lacquer Cracks in High Myopic Patients.
NCT02205632
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The purpose of this study is to compare the short-term changes in choroid thickness, melatonin concentration, and the ipRGC-driven pupillary light response following one hour of light therapy with either short wavelength blue light or long wavelength red light. It has previously been shown that a one week period of daily morning light therapy produces a short term increase in choroid thickness throughout the day. Therefore, the investigators hypothesize that one hour of morning light therapy with short wavelength blue light will result in different effects in the changes in choroid thickness, melatonin levels, and the ipRGC-driven pupillary light response compared to one hour of morning light therapy with long wavelength red light.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Light exposure broadband
Participants will be exposed to indoor levels of light that appear colorless for one hour
White Light therapy
Participants will be exposed to broadband light for one hour
Light exposure long wavelength
Participants will be exposed to indoor levels of light that appear red for one hour
Red light therapy
Participants will be exposed to re light for one hour
Light exposure short wavelength
Participants will be exposed to indoor levels of light that appear blue for one hour
Blue light therapy
Participants will be exposed to blue light for one hour
Light exposure darkness
Participants will be exposed to darkness for one hour
Darkness
Participants will be in complete darkness for one hour
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
White Light therapy
Participants will be exposed to broadband light for one hour
Blue light therapy
Participants will be exposed to blue light for one hour
Red light therapy
Participants will be exposed to re light for one hour
Darkness
Participants will be in complete darkness for one hour
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* must be able to comply with the experimental protocol, including collecting saliva and being present for the experiment in the lab on four separate occasions.
* must be willing to abstain from the use of sleep aids 12 hours prior to and for the duration of the study.
* must also be willing to abstain from alcohol and caffeinated beverages (coffee, espresso, energy drinks) or foods enriched with caffeine, such as power bars, the morning of and during each of the four experimental sessions.
Exclusion Criteria
* not willing to collect a saliva sample or be present in the lab on four separate occasions.
* ocular disease that may affect retinal light levels and function (e.g. glaucoma, significant cataract, etc.)
* use of prescription or over-the-counter medications known to affect sleep and cortisol levels.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Houston
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Houston College of Optometry
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lou L, Ostrin LA. Effects of Narrowband Light on Choroidal Thickness and the Pupil. Invest Ophthalmol Vis Sci. 2020 Aug 3;61(10):40. doi: 10.1167/iovs.61.10.40.
Related Links
Access external resources that provide additional context or updates about the study.
published manuscript
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00001524
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.